No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Solid Biosciences Stock Jumps 11% Post-market on FDA Update
Lexeo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
Press Release: Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer
Express News | Lexeo Therapeutics Inc Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing